{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:42:57Z","timestamp":1791348177476,"version":"4.3.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish Liver Transplant Society","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Spanish Liver Transplant Society","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>MicroRNAs have emerged as potential biomarkers of liver injury during organ transplantation due to their specificity, easy detection and stability in many biofluids. Heparin, which has a well-known inhibitory effect on RT-qPCR based measurements, is commonly used during organ donation. Heparinase I treatment has been used to overcome the inhibiting effect of heparin in RNA RT-qPCR analysis. However, there is a lack of evidence regarding its effective, feasible use improving specific miRNA quantification yield in the liver transplant setting. The aim of this study is to evaluate the effect of heparinase I on miRNA detection levels by RT-qPCR in different samples from liver donors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Prospective, single-centre study including evaluation of liver biopsy, perfusate fluid and serum from deceased organ donors from October 2019 to May 2021. Samples from brain death donors (DBD, n\u2009=\u20094) and donors after circulatory death recovered with abdominal normothermic regional perfusion (DCD n\u2009=\u20094) were analysed for the presence of liver-injury related miRNAs (miR-122 and miR-148a) in the absence or presence of heparinase I (6 IU or 12 IU) to evaluate its effect on miRNA detection levels by RT-qPCR. A subgroup of heparinized serum samples from patients undergoing cardiopulmonary bypass was analysed for validation purposes. The study is registered with ClinicalTrials.gov (NCT06611046), and accrual is complete.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The expression of miR-122 relative to reference genes was 44.5, 16.8 and 4.2-fold higher in liver biopsy, perfusates and serum respectively, while miR-148a was 3.4, 2.2 and 2.6-fold higher, without differential expression between donor groups (p\u2009&gt;\u20090.05). Heparinase I treatment did not improve PCR results and affected miRNA detection yields in a dose-dependent way with delayed and dispersed Ct values. In highly heparinized DCD serum samples, heparinase I treatment significantly reduced the relative expression of miR-122 and miR-148a compared to non-treated samples, 2-fold and 6.1-fold, p\u2009&lt;\u20090.05 respectively. Moreover, treatment with heparinase I led to a rise in lost values, from 12.5% to 25% in perfusates and 67.7% to 68.7% in serum samples treated with 6IU and 12IU of heparinase I respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The need for heparinase I treatment to overcome RNA quantification interference in heparinized samples should be addressed in each individual analysis. Heparin inhibition seems variable among miRNAs, and the additional handling with heparinase may affect reliable miRNA quantification due to RNA degradation, introducing bias in gene expression interpretation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0322899","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T17:52:41Z","timestamp":1747072361000},"page":"e0322899","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Heparinase I treatment to overcome RNA quantification interference in heparinized liver donor samples: One size fits all?"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-0912","authenticated-orcid":true,"given":"Mar","family":"Dalmau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Charco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itxarone","family":"Bilbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Dopazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Caralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-1684","authenticated-orcid":true,"given":"Jos\u00e9 Andr\u00e9s","family":"Molino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8312-3273","authenticated-orcid":true,"given":"Concepci\u00f3n","family":"G\u00f3mez-Gavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"6","key":"pone.0322899.ref001","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/lt.26002","article-title":"Development and validation of a model to predict long-term survival after liver transplantation","volume":"27","author":"D Goldberg","year":"2021","journal-title":"Liver Transpl"},{"issue":"4","key":"pone.0322899.ref002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index","volume":"6","author":"S Feng","year":"2006","journal-title":"Am J Transplant"},{"issue":"9","key":"pone.0322899.ref003","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/TP.0000000000003825","article-title":"Recommendations for donor and recipient selection and risk prediction: working group report from the ILTS consensus conference in DCD liver transplantation","volume":"105","author":"A Schlegel","year":"2021","journal-title":"Transplantation"},{"key":"pone.0322899.ref004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"MR Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"issue":"30","key":"pone.0322899.ref005","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"PS Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"pone.0322899.ref006","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"X Chen","year":"2008","journal-title":"Cell Res"},{"issue":"4","key":"pone.0322899.ref007","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/biomedicines10040791","article-title":"MicroRNAs: novel targets in hepatic ischemia-reperfusion injury","volume":"10","author":"H Ingram","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"pone.0322899.ref008","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/lt.25781","article-title":"Serum MicroRNA signatures in recovery from acute and chronic liver injury and selection for liver transplantation","volume":"26","author":"S Salehi","year":"2020","journal-title":"Liver Transpl"},{"issue":"2","key":"pone.0322899.ref009","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2008.09.015","article-title":"The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma","volume":"50","author":"L Chen","year":"2009","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0322899.ref010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/rna.18827","article-title":"Liver-specific microRNA-122: biogenesis and function","volume":"9","author":"C Jopling","year":"2012","journal-title":"RNA Biol"},{"issue":"1","key":"pone.0322899.ref011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hep.28786","article-title":"An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection","volume":"65","author":"A Shaked","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"pone.0322899.ref012","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/liv.12955","article-title":"Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function","volume":"36","author":"CJ Verhoeven","year":"2016","journal-title":"Liver Int"},{"issue":"3","key":"pone.0322899.ref013","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/lt.22438","article-title":"Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation","volume":"18","author":"WRR Farid","year":"2012","journal-title":"Liver Transpl"},{"issue":"7","key":"pone.0322899.ref014","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.24766","article-title":"The release of microRNA-122 during liver preservation is associated with early allograft dysfunction and graft survival after transplantation","volume":"23","author":"JW Selten","year":"2017","journal-title":"Liver Transpl"},{"issue":"6","key":"pone.0322899.ref015","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2013.07.034","article-title":"MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation","volume":"59","author":"CJ Verhoeven","year":"2013","journal-title":"J Hepatol"},{"issue":"7","key":"pone.0322899.ref016","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1373\/clinchem.2012.199505","article-title":"Heparin selectively affects the quantification of microRNAs in human blood samples","volume":"59","author":"J-N Boeckel","year":"2013","journal-title":"Clin Chem"},{"issue":"1","key":"pone.0322899.ref017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2050-7771-2-13","article-title":"Circumventing qPCR inhibition to amplify miRNAs in plasma","volume":"2","author":"JL Plieskatt","year":"2014","journal-title":"Biomark Res"},{"issue":"6","key":"pone.0322899.ref018","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jmoldx.2016.06.006","article-title":"Improving accuracy of urinary miRNA quantification in heparinized patients using heparinase i digestion","volume":"18","author":"HP Roest","year":"2016","journal-title":"J Mol Diagn"},{"issue":"6","key":"pone.0322899.ref019","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2013.07.034","article-title":"MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation","volume":"59","author":"CJ Verhoeven","year":"2013","journal-title":"J Hepatol"},{"issue":"8","key":"pone.0322899.ref020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","article-title":"Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the royal college of radiologists and the royal college of pathology","volume":"69","author":"J Neuberger","year":"2020","journal-title":"Gut"},{"issue":"873","key":"pone.0322899.ref021","first-page":"1","article-title":"Monitoring of miR-181a-5p and miR-155-5p plasmatic expression as prognostic biomarkers for acute and subclinical rejection in de novo adult liver transplant recipients","volume":"10","author":"O Mill\u00e1n","year":"2019","journal-title":"Front Immunol"},{"key":"pone.0322899.ref022","first-page":"893594","article-title":"Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma","author":"Y Li","year":"2015","journal-title":"Dis Markers"},{"issue":"4","key":"pone.0322899.ref023","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"21","key":"pone.0322899.ref024","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1093\/nar\/19.21.6051","article-title":"Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood","volume":"19","author":"S Izraeli","year":"1991","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pone.0322899.ref025","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2144\/03356bm03","article-title":"Heparinase treatment of RNA before quantitative real-time RT-PCR","volume":"35","author":"ML Johnson","year":"2003","journal-title":"Biotechniques"},{"issue":"1","key":"pone.0322899.ref026","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41598-018-19748-6","article-title":"Establishment of an easy and straightforward heparinase protocol to analyse circulating and myocardial tissue micro-RNA during coronary artery-bypass-graft surgery","volume":"8","author":"A Engler","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0322899.ref027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jmoldx.2011.09.002","article-title":"Plasma components affect accuracy of circulating cancer-related microRNA quantitation","volume":"14","author":"D-J Kim","year":"2012","journal-title":"J Mol Diagn"},{"key":"pone.0322899.ref028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bdq.2016.03.001","article-title":"Heparinase treatment of heparin-contaminated plasma from coronary artery bypass grafting patients enables reliable quantification of microRNAs","volume":"8","author":"K Kondratov","year":"2016","journal-title":"Biomol Detect Quantif"},{"issue":"3","key":"pone.0322899.ref029","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1160\/TH13-05-0368","article-title":"Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease","volume":"110","author":"D Kaudewitz","year":"2013","journal-title":"Thromb Haemost"},{"issue":"7","key":"pone.0322899.ref030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1055\/s-0038-1660437","article-title":"Overcoming heparin-associated RT-qPCR inhibition and normalization issues for microRNA quantification in patients with acute myocardial infarction","volume":"118","author":"J Coelho-Lima","year":"2018","journal-title":"Thromb Haemost"},{"issue":"5","key":"pone.0322899.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127073","article-title":"The microRNA expression profile in Donation after Cardiac Death (DCD) livers and its ability to identify primary non function","volume":"10","author":"SE Khorsandi","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"pone.0322899.ref032","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.22091","article-title":"Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors","volume":"16","author":"KM Olthoff","year":"2010","journal-title":"Liver Transpl"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T17:52:52Z","timestamp":1747072372000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322899"}},"subtitle":[],"editor":[{"given":"Tianwen","family":"Wang,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0322899","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}